April 29, 2002 -- IMPAX Laboratories, Inc. (Nasdaq:IPXL) today announced that
management will present at the CIBC World Markets Annual Biotechnology and Specialty
Pharmaceuticals Conference in New York City on Thursday, May 2, 2002, at 2:00
p.m. (EDT).
The conference will be held at The Millennium Hotel in New York City and attendees
will include institutional money managers and analysts.
IMPAX's presentation can be heard live on the Internet. In addition, an audio
replay will be available the following business day for a period of 90 days.
Please visit the investor relations section of IMPAX's website at http://www.impaxlabs.com/invest
for a link to the Company's presentation.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company
applying its formulation expertise and drug delivery technology to the development
of controlled-release and niche generics in addition to the development of branded
products. IMPAX markets its generic products through its Global Pharmaceuticals
division and intends to market its branded products through the IMPAX Pharmaceuticals
division. IMPAX Laboratories is headquartered in Hayward, California, and has
a full range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.